RecruitingNot Applicable

Improving Work Ability of Young Adults With Stroke

Hong Kong160 participantsStarted 2023-01-01

Plain-language summary

This project will investigate effects of a novel theory-driven 6-week virtual Personal Resource Building and Inclusive Volunteering Intervention (PVI) on young stroke survivors' work ability, self-efficacy and psychosocial outcomes. It is hypothesised that participants in the intervention group, compared with the control group, will demonstrate the outcomes below at immediately and 3 months post-intervention with respect to baseline: 1) Significant improvement in work ability (primary outcome), 2) Significant improvements in self-efficacy, health-related quality of life (HRQoL), emotional well-being and social skills (secondary outcomes). Eligible participants will be randomly assigned to receive usual care or PVI with usual care and the control group participants will receive usual stroke care services.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-64 years old, * been clinically diagnosed with a first-ever or recurrent ischaemic or haemorrhagic stroke, * living at home, * Montreal Cognitive Assessment score \>2nd percentile, * a Modified Rankin Scale of 4 or below (moderately severe disability), * able to communicate in Cantonese and read Traditional Chinese, * a regular paid employment at the time of stroke, * been unemployed for at least 3 months at the time of recruitment. Exclusion Criteria: * have been diagnosed with transient ischaemic attack, * have experienced cerebrovascular events due to tumours, * have been diagnosed with a mental condition such as depression, schizophrenia or bipolar disorder, * demonstrate incomprehensible speech or difficulty in comprehending conversations, or * have or are receiving vocational programmes.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in the level of perceived work ability

Timeframe: Change from baseline level to three months after completion of the intervention

Trial details

NCT IDNCT05902195

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12-31

Contact for this trial

Suzanne Lo

852 3943 4485 suzannelo@cuhk.edu.hk

View on ClinicalTrials.gov More Stroke trials